drugset / Trial / NCT06829329
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is to evaluate the efficacy and safety of AHB-137 in CHB participants. The total duration of the study, including screening phase, treatment phase and follow-up phase.
Timeline
- Start
- 2024-12-13
- Primary completion
- 2026-08-02
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AHB-137 | Antisense oligonucleotide | — | — |